1.
Govindapala D, Dhanaratna D, Senarath U, Lamabadusuriya D, Senaratne T, Wijenayake W, Wijewardena D, Nakkawita D, Kawyangana P, Kulasekara U, De Silva AD, Fernando N. Reactogenicity and persistence of IgG antibodies against SARS-CoV-2 among recipients of ChAdOx1 nCoV-19 vaccine: A single center experience from Sri Lanka. IJHS [Internet]. 2022 Dec. 28 [cited 2024 Nov. 22];17(1):36-43. Available from: https://pub.qu.edu.sa/index.php/journal/article/view/7176